APA (7th ed.) Citation

Kaur, H., Kala, S., Sood, A., Mridha, A. R., Kakkar, A., Yadav, R., . . . Mishra, D. (2022). Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from its Benign Fibro-osseous Lesions. Head and Neck Pathology, 16(3), 728-737. https://doi.org/10.1007/s12105-022-01434-9

Chicago Style (17th ed.) Citation

Kaur, Harpreet, Sunny Kala, Anubhuti Sood, Asit Ranjan Mridha, Aanchal Kakkar, Rahul Yadav, Shashwat Mishra, and Deepika Mishra. "Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from Its Benign Fibro-osseous Lesions." Head and Neck Pathology 16, no. 3 (2022): 728-737. https://doi.org/10.1007/s12105-022-01434-9.

MLA (9th ed.) Citation

Kaur, Harpreet, et al. "Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from Its Benign Fibro-osseous Lesions." Head and Neck Pathology, vol. 16, no. 3, 2022, pp. 728-737, https://doi.org/10.1007/s12105-022-01434-9.